Athira Pharma (ATHA) Insider Trading & Ownership

$2.01
-0.03 (-1.47%)
(As of 04/24/2024 ET)

Athira Pharma (NASDAQ:ATHA) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
17.00%
Number Of
Insiders Buying
(Last 12 Months)
2
Amount Of
Insider Buying
(Last 12 Months)
$706,359.88
Number Of
Insiders Selling
(Last 12 Months)
3
Amount Of
Insider Selling
(Last 12 Months)
$24,560.40
Get ATHA Insider Trade Alerts

Want to know when executives and insiders are buying or selling Athira Pharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

ATHA Insider Buying and Selling by Quarter

Athira Pharma Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
1/5/2024Andrew GengosInsiderSell1,208$2.91$3,515.28  
1/5/2024Mark James LittonCEOSell4,820$2.91$14,026.20  
1/5/2024Mark WorthingtonGeneral CounselSell2,412$2.91$7,018.92  
12/29/2023Perceptive Advisors LlcDirectorBuy163,954$2.38$390,210.52  
12/27/2023Perceptive Advisors LlcDirectorBuy32,134$2.28$73,265.52  
6/7/2023Andrew GengosInsiderBuy15,000$3.43$51,450.00  
6/5/2023Andrew GengosInsiderBuy45,000$3.00$135,000.00  
6/2/2023Andrew GengosInsiderBuy20,012$2.82$56,433.84  
(Data available from 1/1/2013 forward)

ATHA Insider Trading Activity - Frequently Asked Questions

Who is on Athira Pharma's Insider Roster?

The list of insiders at Athira Pharma includes Andrew Gengos, Glenna Mileson, Hans Moebius, James A Johnson, Kelly A Romano, Mark James Litton, Mark Worthington, Perceptive Advisors Llc, and Rachel Lenington. Learn more on insiders at ATHA.

What percentage of Athira Pharma stock is owned by insiders?

17.00% of Athira Pharma stock is owned by insiders. Learn more on ATHA's insider holdings.

Which Athira Pharma insiders have been buying company stock?

The following insiders have purchased ATHA shares in the last 24 months: Andrew Gengos ($242,883.84), Glenna Mileson ($142,500.00), Hans Moebius ($45,250.00), James A Johnson ($12,000.00), Kelly A Romano ($98,700.00), and Perceptive Advisors Llc ($1,270,776.04).

How much insider buying is happening at Athira Pharma?

Insiders have purchased a total of 646,100 ATHA shares in the last 24 months for a total of $1,812,109.88 bought.

Which Athira Pharma insiders have been selling company stock?

The following insiders have sold ATHA shares in the last 24 months: Andrew Gengos ($3,515.28), Mark James Litton ($35,438.60), Mark Worthington ($14,050.58), and Rachel Lenington ($11,279.17).

How much insider selling is happening at Athira Pharma?

Insiders have sold a total of 23,207 Athira Pharma shares in the last 24 months for a total of $64,283.63 sold.


More Insider Trading Tools from MarketBeat

This page (NASDAQ:ATHA) was last updated on 4/24/2024 by MarketBeat.com Staff

From Our Partners